Skip to main content

Table 2 Outcomes of patients with acute respiratory distress syndrome (n = 186)

From: The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study

Variables High-dose group Low-dose group P value
(n = 21) (n = 165)
60-Day mortality 66.6% 41.9% 0.031
Ventilator-free days by day 28 0.0 (0.0–7.5) 10.0 (0.0–19.0) 0.021
Organ-failure-free days by day 28 71.0 (28.5–94.5) 97.0 (48.0–110.0) 0.087
Ventilator-associated pneumonia 9 (42.9%) 62 (37.6%) 0.639
  1. Data are presented as median (IQR), unless otherwise stated